Keywords
Abstract
Ҳозирги кунда мавжуд маълумотлар MMП ва TИMП генларидаги полиморфизмлар вирусли инфекциялар, шу жумладан COVID-19 пайтида, миокарддаги яллиғланиш даражаси ва тузилма ўзгаришларга сезиларли таъсир кўрсатиши мумкинлигини кўрсатади. Аммо тадқиқотлар натижалари ҳанузгача зидли бўлиб қолмоқда, бу эса тадқиқот олиб борилган популяциялар, методологиялар ва баҳолаш мезонларидаги фарқлар билан боғлиқ. Бундан ташқари, ўтказилган тадқиқотларнинг аксарияти миокардитдаги яллиғланишнинг умумий жиҳатларини ўрганишга қаратилган бўлиб, MMП ва TИMП генларидаги генетик вариантлар билан боғлиқ аниқ механизмлар етарлича ўрганилмаган.
References
1. Moiseev VS., Kiyakbaev GK. Lazarev PV. Cardiomyopathies and myocarditis: a guide / Library of a specialist: cardiology. GEOTAR-Media, 2020. - 512 с. (in Russ). https://pubmed.ncbi.nlm.nih.gov/33046850/
2. Srozhidinova NZ., Nizamov UI., Fozilov HG. et al. National clinical protocol for the management of patients with myocarditis. Uzbek. Res. SSV Tashkent –2021.11.30.(273) 840-882с. (in Uzb). https://lex.uz/uz/docs/897151?ONDATE=10.12.1993&ONDATE2=22.02.2021&action=compare
3. Arutyunov GP., Paleev FN., Moiseeva OM., et al. Myocarditis in adults. Clinical recommendations Russian Journal of Cardiology 2021;26(11):4790.1-47с. (in Russ). https://russjcardiol.elpub.ru/jour/article/view/4790?locale=ru_RU.
4. Nikiforov VV, Kolobukhina LV, Smetanina SV. New coronavirus infection (COVID-19): etiology, epidemiology, clinical picture, diagnostics, treatment and prevention. // Study guide 2020; C1-70. (in Russ). https://doi.org/10.20514/2226-6704-2020-10-2-87-93.
5. Abaturov AE, Agafonova EA, Krivusha EL. Pathogenesis of Covid-19. Journal of Child Health. 2020;15(2):133–44c. (in Russ). https://cyberleninka.ru/article/n/patogenez-covid-19/viewer.
6. Pericarditis. Approved by the minutes of the meeting of the Expert Commission on Healthcare Development of the Ministry of Health of the Republic of Kazakhstan No. 13 dated 28.06.2013. 1-46 p. (in Russ). https://nrchd.kz/docs/clinic_protocol/%D0%A2%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8F/%D0%9A%D0%B0%D1%80%D0%B4%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F/%D0%9F%D0%B5%D1%80%D0%B8%D0%BA%D0%B0%D1%80%D0%B4%D0%B8%D1%82.pdf
7. Chen T., Wu D., Chen H. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Cite this as: BMJ Journal. 31.03.2020;368:m1091. https://doi.org/10.1136/bmj.m1091.
8. Driggin E, Madhavan V., Bikdeli B. et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. Journal J Am Coll Cardiol. 2020; May 12 75 (18):2352-2371. https://pubmed.ncbi.nlm.nih.gov/32201335/.
9. Chen N., Zhou M., Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Journal: The Lancet 2020;395:2(3) 507-13с. https://pubmed.ncbi.nlm.nih.gov/32007143/.
10. Yoshikawa T., Hill T., Li K. et al. Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells. Journal of virology. 2009 Apr 1;83(7):3039-3048. https://pubmed.ncbi.nlm.nih.gov/19004938/
11. Hoffmann, M., Kleine-Weber, H., Schroeder, S. et al.SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020 Apr.16;181(2):271-280.e8. https://pubmed.ncbi.nlm.nih.gov/32142651/